RNF135 and neurofibroma: Given the early worsening of the clinical phenotype, we evaluated a possible expression deregulation of SUZ12 and the other PRC2 components, RNF135 and their target genes, often involved in cancer, to verify their potential role on the early onset of numerous neurofibromas, addressing development of personalized medicine.